Paul Lammers serves as Executive at Salarius Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Paul Lammers has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jan 3, 2023 involved receiving (via award) 1,440 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jan 3, 2023 | SLRX | $0 | Award | 1,440 | $N/A | Discretionary |
Paul Lammers currently holds 1,718 shares of Salarius Pharmaceuticals, Inc. (SLRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Lammers has been a net neutral trader of SLRX stock. They have purchased $0 and sold $0 worth of shares.
Paul Lammers's most recent insider trade was on Jan 3, 2023, when they sold 1,440 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted